FDA denies approval of Depo-Provera in U.S. for contraception; risks outweigh benefits.
D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration
D008525:Medroxyprogesterone